2011-11-15T08:27:22-06:00 2010-12-31 MOUNTJOY CHILTON MEDLEY LLP 462 S FOURTH ST 2000 MEIDINGER TOWE LOUISVILLE KY 402023445 990 2010-01-01 830392250 NATIONAL FOUNDATION TO SUPPORT CELL TRANSPLANT RESEARCH INC NATI 5023798544 333 E MAIN ST NO 400 LOUISVILLE KY 40202 DIANE CORNWELL 5023798544 2011-11-14 1 REBECCA L PHILLIPS CPA 5027491900 2010 2016-03-07 17:11:31Z X DR PAULA GRISANTI 333 E MAIN ST NO 400 LOUISVILLE KY 40202 1541052 0 X WWW.NFCTR.ORG X 2003 DC TO FUND, PROMOTE AND SUPPORT COLLABORATION BETWEEN RESEARCHERS IN THE FIELD OF ADULT STEM CELL TRANSPLANTATION, FUND PATIENTS PARTICIPATING IN THE RESULTING EARLY STAGE CLINICAL TRIALS, IMPROVE THE LIVES OF PEOPLE WORLDWIDE SUFFERING FROM DISEASES AND CONDITIONS THAT MAY BENEFIT FROM ADULT STEM CELL RESEARCH, AND MAKE CURATIVE THERAPIES ACCESSIBLE TO ALL. 5 5 1 10 0 0 291238 1540484 0 0 1966 568 25 0 293229 1541052 746107 1548687 0 0 48506 49727 0 0 25157 455339 431548 1249952 2029962 -956723 -488910 2953246 3198911 2196252 2974380 756994 224531 X TO FUND, PROMOTE AND SUPPORT COLLABORATION BETWEEN RESEARCHERS IN THE FIELD OF ADULT STEM CELL TRANSPLANTATION, FUND PATIENTS PARTICIPATING IN THE RESULTING EARLY STAGE CLINICAL TRIALS, IMPROVE THE LIVES OF PEOPLE WORLDWIDE SUFFERING FROM DISEASES AND CONDITIONS THAT MAY BENEFIT FROM ADULT STEM CELL RESEARCH, AND MAKE CURATIVE THERAPIES ACCESSIBLE TO ALL. 0 0 1950760 1548687 THE PROMOTION AND SUPPORT OF COLLABORATION BETWEEN RESEARCHERS IN THE FIELD OF ADULT STEM CELL TRANSPLANTATION, FUNDING OF PATIENTS PARTICIPATING IN THE RESULTING EARLY STAGE CLINICAL TRIALS, IMPROVEMENT OF THE LIVES OF PEOPLE WORLDWIDE SUFFERING FROM DISEASES AND CONDITIONS THAT MAY BENEFIT FROM ADULT STEM CELL RESEARCH AND MAKING CURATIVE THERAPIES ACCESSIBLE TO ALL. 1950760 1 1 0 0 0 0 0 0 0 0 1 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 7 0 1 1 1 0 0 0 0 0 0 0 0 0 0 X 5 5 1 1 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 KY X PAULA GRISANTI DMD 5023798544 333 E MAIN STREET SUITE 400 LOUISVILLE KY 40202 X PAULA GRISANTI 40.00 X X 0 0 0 C DENNIS RIGGS 1.00 X X 0 0 0 MICHAEL GRISANTI 2.00 X 0 0 0 BRUCE S WOLFF 5.00 X 0 0 0 JOHN M CRANOR III 1.00 X 0 0 0 0 0 0 0 0 0 0 0 1401000 139484 1540484 568 568 1541052 0 0 568 1548687 1548687 46217 17650 9522 19045 3510 1404 702 1404 37948 1395 36553 320 320 6676 2385 2260 2031 1593 749 207 637 355 355 340 160 44 136 296 296 9944 9944 62123 61058 1065 32901 30874 498 1529 PATENT MAINTENANCE FEES 200000 200000 INTELLECTUAL PROPERTY C 75803 75803 MISCELLANEOUS EXPENSE 3249 2874 375 2029962 1950760 54045 25157 681637 415078 1134237 1716979 6891 3252 3936 2401 1336 1535 241684 180626 887461 881441 2953246 3198911 1295065 1468490 652575 1257278 185000 185000 63612 63612 2196252 2974380 X 637194 41824 119800 182707 756994 224531 2953246 3198911 X -488910 -43553 X X 0 1 1 X 0 X 317570 157171 84885 235221 1540484 2335331 317570 157171 84885 235221 1540484 2335331 140144 2195187 65 2587 11544 1966 568 16730 410 25 435 2352496 0.93310 0.68850 X SCHEDULE A, PART IV, SUPPLEMENTAL INFORMATION: DURING 2010, THE FOUNDATION DISCOVERED A PLEDGE PAYMENT INADVERTENTLY CLASSIFIED AS CONTRIBUTION REVENUE AND NOT APPLIED TO THE PLEDGE RECEIVABLE DURING 2007. TO ADJUST FOR THIS THE ORGANIZATION HAS REDUCED ITS 2007 CONTRIBUTION REVENUE REPORTED IN PART II OF SCHEDULE A AS WELL AS ADJUSTED THE AMOUNT USED IN ITS EXCESS CONTRIBUTOR CALCULATION ON LINE 5 OF SCHEDULE A, PART II. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 3936 2401 1535 1535 DEFERRED RESEARCH AND DEVELOPMENT 881441 881441 1541052 2029962 -488910 -43553 -43553 -532463 1717334 176282 176282 1541052 0 1541052 2206244 176282 176282 2029962 0 2029962 1 UNIVERSITY OF LOUISVILLE FOUNDATION CONTROLLERS OFFICE UNIVERSITY OF LOUISVILLE LOUISVILLE KY 40292 237078461 501(C)(3) 9625 RESEARCH AND ADVANCEMENT OF CLINICAL TRIALS ASSOCIATED WITH ADULT STEM CELL THERAPIES. UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION CONTROLLERS OFFICE UNIVERSITY OF LOUISVILLE LOUISVILLE KY 40292 611029626 501(C)(3) 1141221 12906 BOOK REAGENTS FOR RESEARCH BY INSTITUTE FOR CELLUART RESEARCH AND ADVANCEMENT OF CLINICAL TRIALS ASSOCIATED WITH ADULT STEM CELL THERAPIES. NORTHWESTERN UNIVERSITY 633 CLARK STREET EVANSTON IL 60208 362167817 501(C)(3) 384935 RESEARCH AND ADVANCEMENT OF CLINICAL TRIALS ASSOCIATED WITH ADULT STEM CELL THERAPIES. 3 PROCEDURE FOR MONITORING GRANTS IN THE U.S.: PART I, LINE 2: SCHEDULE I, PART I, LINE 2: THE ORGANIZATION MEETS REGULARLY WITH REPRESENTATIVES FROM THE GRANT RECIPIENT(S) AND RECEIVES UPDATES AND REPORTS REGARDING EXPENDITURE OF THE FUNDS. FORM 990, PART VI, SECTION A, LINE 2 PAULA GRISANTI, CHAIRMAN OF THE BOARD, AND MICHAEL GRISANTI, SECRETARY/TREASURER, HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION A, LINE 3 THE ORGANIZATION HAS CONTRACTED ITS FINANCIAL MANAGEMENT OVERSIGHT TO AN OUTSIDE CHIEF FINANCIAL OFFICER. FORM 990, PART VI, SECTION B, LINE 11 FORM 990 WAS PREPARED BY OUTSIDE ACCOUNTING FIRM AND REVIEWED IN DETAIL BY CONTRACT CFO AND BOARD CHAIR. A COPY WAS THEN SENT TO EACH BOARD MEMBER FOR THEIR REVIEW BEFORE THE FORM 990 WAS FILED. FORM 990, PART VI, SECTION B, LINE 12C EVERY PROPOSED TRANSACTION IS REVIEWED TO DETERMINE WHETHER A POSSIBLE CONFLICT COULD EXIST. TO DATE NO POTENTIAL CONFLICTS HAVE BEEN IDENTIFIED. FORM 990, PART VI, SECTION B, LINE 15 POLICY HAS BEEN ADOPTED; HOWEVER CURRENTLY THE CHAIR AND OTHER OFFICERS SERVE WITHOUT COMPENSATION. CONTRACTED CFO IS PAID ON AN HOURLY BASIS. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. CHANGES IN NET ASSETS OR FUND BALANCES: FORM 990, PART XI, LINE 5: PRIOR PERIOD ADJUSTMENTS: -43,553. FORM 990, PART XII, LINE 2C: THE PROCESS HAS NOT CHANGED FROM PRIOR YEAR. THE ORGANIZATION'S BOARD OF DIRECTORS CONTINUE TO SELECT THE INDEPENDENT ACCOUNTANT. THE COMMITTEE CONTINUES TO MEET WITH THE INDEPENDENT AUDITOR AT THE CONCLUSION OF THE ANNUAL AUDIT.